Trials / Not Yet Recruiting
Not Yet RecruitingNCT07213713
Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate appropriateness of enoxaparin bioavailability at two different sites of subcutaneous administration (arms or abdomen) in primary or secondary prevention of thromboembolism in a population of patients with severe obesity
Conditions
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2027-10-01
- Completion
- 2027-10-01
- First posted
- 2025-10-09
- Last updated
- 2025-10-09
Source: ClinicalTrials.gov record NCT07213713. Inclusion in this directory is not an endorsement.